adenoviru vector vaccine highly effect strategy induce cellular immune response particularly intracellular pathogen recombin similar vector develop circuit limit impose use human adenovirus due widespread seropreval neutral antibody construct replica deficit adenovirusvector vaccine shadow express gene mycobacterium album suspect paratuberculosi apc god p mpa safety cell immunogen result first clinic vector present trial conduct use threeplusthre dose escale studi design demons safe well tower immunogen 